(Updated - February 18, 2022 9:41 AM EST)

Karyopharm Therapeutics (NASDAQ: KPTI) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Rumors Trader Talk

Karyopharm Therapeutics (KPTI) Wild Ride Occurring as M&A Speculation Proved Wrong Amid Executive Departure - RBCFebruary 22, 2022 12:40 PM Morgan Stanley Reiterates Equalweight Rating on Karyopharm Therapeutics (KPTI), 'lack of potential takeout news likely to disappoint'February 22, 2022 10:33 AM Karyopharm Therapeutics (KPTI) CEO Cancels Leerink Conf On Scheduling Difficulties - BloombergFebruary 18, 2022 10:15 AM